| 21 |
|
Cell Cycle-dependent Regulation of the Skp2 Promoter by GA-binding Protein/
|
Imaki, H
|
Williams and Wilkins
|
2003
|
|
|
|
| 22 |
|
Cell Growth Regulatory Role of Runx2 during Proliferative Expansion of Preosteoblasts/
|
Pratap, J
|
Williams and Wilkins
|
2003
|
|
|
|
| 23 |
|
CEP-701 and CEP-751 Inhibit Constitutively Activated RET Tyrosine Kinase Activity and Block Medullary Thyroid Carcinoma Cell Growth/
|
Strock, C. J
|
Williams and Wilkins
|
2003
|
|
|
|
| 24 |
|
CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models/
|
Ruggeri, B
|
Williams and Wilkins
|
2003
|
|
|
|
| 25 |
|
Characterization of a Novel Cyclin-Dependent Kinase 1 Inhibitor, BMI-1026/
|
Seong, Y.-S
|
Williams and Wilkins
|
2003
|
|
|
|
| 26 |
|
Characterization of Sporadic Colon Cancer by Patterns of Genomic Instability/
|
Goel, A
|
Williams and Wilkins
|
2003
|
|
|
|
| 27 |
|
Chronic Lymphocytic Leukemia with Prostate Infiltration Mediated by Specific Clonal Membrane-bound IgM/
|
Bogdan, C. A
|
Williams and Wilkins
|
2003
|
|
|
|
| 28 |
|
Class I Alcohol Dehydrogenase Is Highly Expressed in Normal Human Mammary Epithelium but not in Invasive Breast Cancer: Implications for Breast Carcinogenesis/
|
Triano, E. A
|
Williams and Wilkins
|
2003
|
|
|
|
| 29 |
|
Common Genetic Evolutionary Pathways in Familial Adenomatous Polyposis Tumors/
|
Tarafa, G
|
Williams and Wilkins
|
2003
|
|
|
|
| 30 |
|
Comparison of Immunohistochemistry with Reverse Transcription-PCR for the Detection of Micrometastatic Prostate Cancer in Lymph Nodes/
|
Shariat, S. F
|
Williams and Wilkins
|
2003
|
|
|
|
| 31 |
|
Competing Autocrine Pathways Involving Alternative Neuropilin-1 Ligands Regulate Chemotaxis of Carcinoma Cells/
|
Bachelder, R. E
|
Williams and Wilkins
|
2003
|
|
|
|
| 32 |
|
Complementary Effects of Platelet-derived Growth Factor Autocrine Stimulation and p53 or Ink4a-Arf Deletion in a Mouse Glioma Model/
|
Hesselager, G
|
Williams and Wilkins
|
2003
|
|
|
|
| 33 |
|
Complete Protection by High-Dose Dexamethasone against the Hepatotoxicity of the Novel Antitumor Drug Yondelis (ET-743) in the Rat/
|
Donald, S
|
Williams and Wilkins
|
2003
|
|
|
|
| 34 |
|
Complex Regulation of the Fibroblast Growth Factor-binding Protein in MDA-MB-468 Breast Cancer Cells by CCAAT/Enhancer-binding Protein beta/
|
Kagan, B. L
|
Williams and Wilkins
|
2003
|
|
|
|
| 35 |
|
Comprehensive Gene Expression Analysis of Peroxisome Proliferator-treated Immortalized Hepatocytes: Identification of Peroxisome Proliferator-activated Receptor alpha-dependent Growth Regulatory Genes/
|
Tien, E. S
|
Williams and Wilkins
|
2003
|
|
|
|
| 36 |
|
Concomitant Suppression of Hyperlipidemia and Intestinal Polyp Formation in Apc-deficient Mice by Peroxisome Proliferator-activated Receptor Ligands/
|
Niho, N
|
Williams and Wilkins
|
2003
|
|
|
|
| 37 |
|
Congenic Rats Reveal Three Independent Copenhagen Alleles within the Mcs1 Quantitative Trait Locus That Confer Resistance to Mammary Cancer/
|
Haag, J. D
|
Williams and Wilkins
|
2003
|
|
|
|
| 38 |
|
Consequences of Telomerase Inhibition and Combination Treatments for the Proliferation of Cancer Cells/
|
Chen, Z
|
Williams and Wilkins
|
2003
|
|
|
|
| 39 |
|
Constitutive Activation of Nuclear Factor kappaB p50/p65 and Fra-1 and JunD Is Essential for Deregulated Interleukin 6 Expression in Prostate Cancer/
|
Zerbini, L. F
|
Williams and Wilkins
|
2003
|
|
|
|
| 40 |
|
Contributions of ATM Mutations to Familial Breast and Ovarian Cancer/
|
Thorstenson, Y. R
|
Williams and Wilkins
|
2003
|
|
|
|